Ghent University Academic Bibliography

Show Sort by

Your filters: cql: affiliation exact FW cql: author exact 801000673502

Add to list
- Journal Article
- A1
- open access
Building a human physiologically based pharmacokinetic model for aflatoxin B1 to simulate interactions with drugs

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Jia Ning, Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and An Vermeulen (UGent)

(2023) PHARMACEUTICS. 15(3).
Add to list
- Conference Paper
BUILDING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR A CARCINOGENIC FOOD CONTAMINANT

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , an vermeulen, jia ning, Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) and Sarah De Saeger (UGent)

(2023)
Add to list
- Conference Paper
- C3
- open access
Determination of pharmacokinetic parameters of efavirenz and aflatoxin B1 : an approach to unravel possible interactions

Orphélie Lootens, An Vermeulen (UGent) , Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and Marthe De Boevre (UGent)

(2022) World Mycotoxin Forum, 13th Conference, Abstracts.
Add to list
- Conference Paper
- C3
- open access
Determination of pharmacokinetic parameters of efavirenz an aflatoxin B1 : an approach to unravel possible interactions

Orphélie Lootens (UGent) , An Vermeulen (UGent) , Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and Marthe De Boevre (UGent)

(2022) Research Day 2022, Abstracts.
Add to list
- Conference Paper
- C3
High throughput analytical report writing in R : a case study of validating an LC-MS method for the quantification of amoxicillin in human plasma

Pieter-Jan De Sutter (UGent) , Elke Gasthuys (UGent) , An Vermeulen (UGent) and Jan Van Bocxlaer (UGent)

(2022) 24th International Reid Bioanalytical Forum, Abstracts.
Add to list
- Journal Article
- A1
- open access
Altered intravenous drug disposition in people living with cystic fibrosis : a meta‐analysis integrating top‐down and bottom‐up data

Pieter-Jan De Sutter (UGent) , Maxime Van Haeverbeke (UGent) , Eva Van Braeckel (UGent) , Stephanie Van Biervliet (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Elke Gasthuys (UGent)

(2022) CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 11(8). p.951-966
Add to list
- Journal Article
- A1
- open access
Unravelling the pharmacokinetics of aflatoxin B1 : in vitro determination of Michaelis-Menten constants, intrinsic clearance and the metabolic contribution of CYP1A2 and CYP3A4 in pooled human liver microsomes

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Sarah De Saeger (UGent)

(2022) FRONTIERS IN MICROBIOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
Possible mechanisms of the interplay between drugs and mycotoxins : is there a possible impact?

Orphélie Lootens (UGent) , An Vermeulen (UGent) , Siska Croubels (UGent) , Sarah De Saeger (UGent) , Jan Van Bocxlaer (UGent) and Marthe De Boevre (UGent)

(2022) TOXINS. 14(12).
Add to list
Physiologically based pharmacokinetic modelling of lisinopril in children: A case story of angiotensin converting enzyme inhibitors

Feifan Xie, Jan Van Bocxlaer (UGent) and An Vermeulen (UGent)

(2021) BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 87(3). p.1203-1214
Add to list
- Conference Paper
- C3
- open access
Mycotoxin-drug interactions at the level of CYP450 enzymes

Orphélie Lootens (UGent) , Sarah De Saeger (UGent) , Marthe De Boevre (UGent) , An Vermeulen (UGent) and Jan Van Bocxlaer (UGent)

(2021) Research Day 2021, Abstracts.

Academic Bibliography

Building a human physiologically based pharmacokinetic model for aflatoxin B1 to simulate interactions with drugs

BUILDING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR A CARCINOGENIC FOOD CONTAMINANT

Determination of pharmacokinetic parameters of efavirenz and aflatoxin B1 : an approach to unravel possible interactions

Determination of pharmacokinetic parameters of efavirenz an aflatoxin B1 : an approach to unravel possible interactions

High throughput analytical report writing in R : a case study of validating an LC-MS method for the quantification of amoxicillin in human plasma

Altered intravenous drug disposition in people living with cystic fibrosis : a meta‐analysis integrating top‐down and bottom‐up data

Unravelling the pharmacokinetics of aflatoxin B1 : in vitro determination of Michaelis-Menten constants, intrinsic clearance and the metabolic contribution of CYP1A2 and CYP3A4 in pooled human liver microsomes

Possible mechanisms of the interplay between drugs and mycotoxins : is there a possible impact?

Physiologically based pharmacokinetic modelling of lisinopril in children: A case story of angiotensin converting enzyme inhibitors

Mycotoxin-drug interactions at the level of CYP450 enzymes

Contents

Support

Contact